These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25346126)

  • 1. [Clinicopathological significance of Sox17 and β-catenin protein of Wnt in oligodendroglioma].
    Li J; Abulajiang G; Miao N; Li X; Sang W; Liu X; Chu H; Zhang W
    Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):546-50. PubMed ID: 25346126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of chromosome 1p/19q loss of heterozygosity and Sox17 expression in oligodendrogliomas.
    Li J; Miao N; Liu M; Cui W; Liu X; Li X; Shi X; Qing S; Ma Y; Zhang W; Biekemituofu H
    Int J Clin Exp Pathol; 2014; 7(12):8609-15. PubMed ID: 25674225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the Wnt/beta-catenin pathway in human oligodendroglioma cells by Sox17 regulates proliferation and differentiation.
    Chen HL; Chew LJ; Packer RJ; Gallo V
    Cancer Lett; 2013 Jul; 335(2):361-71. PubMed ID: 23474492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/β-catenin signalling regulates Sox17 expression and is essential for organizer and endoderm formation in the mouse.
    Engert S; Burtscher I; Liao WP; Dulev S; Schotta G; Lickert H
    Development; 2013 Aug; 140(15):3128-38. PubMed ID: 23824574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical Analysis of Sox17 Associated Pathway in Brain Arteriovenous Malformations.
    Hermanto Y; Takagi Y; Ishii A; Yoshida K; Kikuchi T; Funaki T; Mineharu Y; Miyamoto S
    World Neurosurg; 2016 Mar; 87():573-83.e1-2. PubMed ID: 26463399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX17 is a tumor suppressor in endometrial cancer.
    Zhang Y; Bao W; Wang K; Lu W; Wang H; Tong H; Wan X
    Oncotarget; 2016 Nov; 7(46):76036-76046. PubMed ID: 27738313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sox17 and β-catenin co-occupy Wnt-responsive enhancers to govern the endoderm gene regulatory network.
    Mukherjee S; Chaturvedi P; Rankin SA; Fish MB; Wlizla M; Paraiso KD; MacDonald M; Chen X; Weirauch MT; Blitz IL; Cho KW; Zorn AM
    Elife; 2020 Sep; 9():. PubMed ID: 32894225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
    Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma.
    Jia Y; Yang Y; Liu S; Herman JG; Lu F; Guo M
    Epigenetics; 2010; 5(8):743-9. PubMed ID: 20716954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis.
    Du YC; Oshima H; Oguma K; Kitamura T; Itadani H; Fujimura T; Piao YS; Yoshimoto T; Minamoto T; Kotani H; Taketo MM; Oshima M
    Gastroenterology; 2009 Oct; 137(4):1346-57. PubMed ID: 19549530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine-Tuning of Sox17 and Canonical Wnt Coordinates the Permeability Properties of the Blood-Brain Barrier.
    Corada M; Orsenigo F; Bhat GP; Conze LL; Breviario F; Cunha SI; Claesson-Welsh L; Beznoussenko GV; Mironov AA; Bacigaluppi M; Martino G; Pitulescu ME; Adams RH; Magnusson P; Dejana E
    Circ Res; 2019 Feb; 124(4):511-525. PubMed ID: 30591003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
    Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
    Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX7 co-regulates Wnt/β-catenin signaling with Axin-2: both expressed at low levels in breast cancer.
    Liu H; Mastriani E; Yan ZQ; Yin SY; Zeng Z; Wang H; Li QH; Liu HY; Wang X; Bao HX; Zhou YJ; Kou JJ; Li D; Li T; Liu J; Liu Y; Yin L; Qiu L; Gong L; Liu SL
    Sci Rep; 2016 May; 6():26136. PubMed ID: 27188720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic significance of β-catenin protein and loss of heterozygosity on 10q in medulloblastoma].
    Li JZ; Wang CH; Zhou FA; Miao N; Abulajang G; Zhang W
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):823-7. PubMed ID: 23324231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insight, mutation and interactions in human Beta-catenin and SOX17 protein: A molecular-level outlook for organogenesis.
    Banerjee A; Ray S
    Gene; 2017 Apr; 610():118-126. PubMed ID: 28132771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer.
    Jia Y; Yang Y; Zhan Q; Brock MV; Zheng X; Yu Y; Herman JG; Guo M
    J Mol Diagn; 2012 Nov; 14(6):577-85. PubMed ID: 22921431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of ABCA2' a possible molecular marker for oligodendrogliomas.
    Soichi O; Masanori N; Hideo T; Kazunori A; Nobuya I; Jun-ichi K
    Neurosurgery; 2007 Apr; 60(4):707-14; discussion 714. PubMed ID: 17415208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lhx3 is required to maintain cancer cell development of high-grade oligodendroglioma.
    Liu H; Liu W; Zhu B; Xu Q; Ni X; Yu J
    Mol Cell Biochem; 2015 Jan; 399(1-2):1-5. PubMed ID: 25399296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
    Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL
    Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients.
    Cui J; Xi H; Cai A; Bian S; Wei B; Chen L
    Int J Mol Med; 2014 Jul; 34(1):197-204. PubMed ID: 24788044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.